FDA approves new ALS drug tested in clinical trial at UF
AMX0035 was tested at UF, Mass General and partnering sites and then approved by the FDA to treat ALS.
Posted in
MBI News
College implements well-being index targeting precision wellness in residents, fellows
Drs. Christina Bulleit and Lisa Merlo lead efforts to help residents, fellows manage their mental health.
UF neurologist co-leading landmark study on autism’s role in aging
Study co-led by Dr. Brandon Zielinski aims to shed new light on how autism is affected by the aging process.
Parkinson disease treatment advances
Drs. Irene Malaty and Bhavana Patel co-author review in Practical Neurology about new agents, formulations and procedures to improve Parkinson’s treatment.
Engineering the hi-fi brain
Dr. Kevin Otto co-leads public-private UF collaboration seeking to optimize clinical outcomes through novel neuroprostheses fabrication.
Postdoc Appreciation Week
UF postdocs working in neuroscience, psychiatry and neuromedicine: Join us for our MBI National Postdoc Appreciation Week events!
Tourette syndrome and tic disorders clinic renewed as Center of Excellence
Norman Fixel Institute received renewal as a Tourette Association of America Center of Excellence for an additional three years.
Identifying optimal timing of physical therapy to mitigate Parkinson’s symptoms
Drs. Ramzi Salloum and Michael Okun co-authored new JAMA Neurology viewpoint article.
DBS trial for difficult-to-treat Tourette syndrome shows promise
Human trial of closed-loop DBS in four participants with difficult-to-treat Tourette syndrome finds treatment to be safe, beneficial.
UF researcher receives grant to study dura mater grafts
Dr. Lakiesha Williams will lead a $1.7M NIH grant comparing the effectiveness of different dura mater grafts.
